Abeona Therapeutics Inc. Quarterly report pursuant to Section 13 or 15(d)

Stock Based Compensation and Restricted Stock Compensation (Tables)

3 Months Ended

Mar. 31, 2016

The following table summarizes stock-based compensation for the three months ended March 31, 2016 and 2015:

	Three months ended March 31,
	2016		2015
Research and development	$	341,000	$	18,000
General and administrative		1,251,000		206,000
Stock-based compensation expense included in operating expense	$	1,592,000	$	224,000

The following table summarizes restricted stock compensation expense for the three months ended March 31, 2016 and 2015:

	Three months ended March 31,
	2016		2015
Research and development	$	62,000	$	-
General and administrative		1,830,000		-
Stock-based compensation expense included in operating expense	$	1,892,000	$	-